Sunshine Biopharma Inc (SBFM)

[TenKay]

“There is a risk that all the shares are converted, but there is a risk that Sunshine pays off the loan prior to all of it converting. I don't fault RB if they convert and sell some of their shares to guarantee a profit.”

There is no way that note is being paid off. It is being used to fund the $2 million. It is an interesting way to get around Rule 144 for the new notes. They essential take a $122K note that is aged and reset the conversion to $0.001 which makes the shares upon conversion worth $10 million at the current pps. That is a boatload of dilution. They then only need to return $2 million (actually much less than that, because the new notes have some value upon conversion) for that “$10 million”.

In essence the are selling free trading stock at a 80-90% discount to market.